A doctor involved in the multidistrict litigation (MDL) over the marketing of testosterone replacement drugs, who was one of the biggest proponents of the drugs’ use for more conditions has been ordered to turn over records of payments he received from the drugs’ manufacturers. U.S. District Judge Matthew Kennelly, an Illinois federal judge, issued this ruling last month. Pursuant to the ruling, Dr. Abraham Morgantaler will have to turn over any tax forms recording payments he received from 18 pharmaceutical companies involved in the MDL. The drugmakers are accused of aggressively marketing their products while downplaying the risks of heart attacks and stroke associated with them.
Judge Kennelly’s ruling ends Dr. Morgantaler’s lengthy battle against a subpoena served on him by the Plaintiffs’ Steering Committee. The doctor has been portrayed as actively shaping “the science, marketing, and use of [testosterone replacement therapy] products involved in these MDL proceedings.” Steering committee counsel Chris Seeger reiterated the importance of Dr. Morgantaler as a third-party witness.
Dr. Morgantaler has been one of the biggest proponents of using the products to treat symptoms of male aging like weight gain and lowered libido. Dr. Morgantaler founded the Androgen Study Group, a multidisciplinary group that reviews studies done on testosterone therapy. In addition to the payment records, Dr. Morgantaler was ordered to turn over PowerPoints he made for presentations about testosterone replacement for other doctors and medical schools.
Bellwether trials against the Defendant drug companies are expected to begin next year. The Plaintiffs are represented by Trent Miracle of Simmons Hanly Conroy; Ronald Johnson Jr. of Schachter Hendy & Johnson; and Chris Seeger of the Seeger Weiss firm. The case is In Re: Testosterone Replacement Therapy Products Liability Litigation in the U.S. District Court for the Northern District of Illinois.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.